Firzan Nainu
Akiko Shiratsuchi
Yoshinobu Nakanishi- 1Laboratory of Pharmacology and Toxicology, Faculty of Pharmacy, Hasanuddin University, Makassar, Indonesia
- 2Laboratory of Host Defense and Responses, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan
Viruses are infectious entities that hijack host replication machineries to produce their progeny, resulting, in most cases, in disease and, sometimes, in death in infected host organisms. Hosts are equipped with an array of defense mechanisms that span from innate to adaptive as well as from humoral to cellular immune responses. We previously demonstrated that mouse cells underwent apoptosis in response to influenza virus infection. These apoptotic, virus-infected cells were then targeted for engulfment by macrophages and neutrophils. We more recently reported similar findings in the fruit fly Drosophila melanogaster, which lacks adaptive immunity, after an infection with Drosophila C virus. In these experiments, the inhibition of phagocytosis led to severe influenza pathologies in mice and early death in Drosophila. Therefore, the induction of apoptosis and subsequent phagocytosis of virus-infected cells appear to be an antiviral innate immune mechanism that is conserved among multicellular organisms. We herein discuss the underlying mechanisms and significance of the apoptosis-dependent phagocytosis of virus-infected cells. Investigations on the molecular and cellular features responsible for this underrepresented virus–host interaction may provide a promising avenue for the discovery of novel substances that are targeted in medical treatments against virus-induced intractable diseases.
Introduction
Viruses are one of the most abundant entities present in the environment. All species, including microbial pathogens, such as bacteria and fungi, are subject to infections by viruses (1, 2). Greater susceptibility to viral infection has been reported in higher metazoans, such as humans, which live in a community system (3). In this system, close interactions exist between species, and, thus, infection easily spreads among members of the community (3), particularly under the condition of compromised immunity (4). Irrespective of the types of genomes and other structural and functional characteristics, viruses behave in a similar manner after invading host organisms. Most viruses, if not all, are obligate intracellular parasites and, thus, require immediate access to the cytosolic and/or nuclear compartments of host cells (2, 5). In the cytoplasm, viruses hijack the ribosomes of host cells to generate proteins encoded by their own genomes for the production of new infective virions (5–8). In the nucleus, viruses may utilize, when necessary, host enzymes to replicate their genomes and synthesize mRNA. On the other hand, host cells are equipped with an array of intracellular and extracellular immune responses to limit this viral proliferation process (9, 10). The final result of this race between the host and virus decides the outcome of infection, from which infected host organisms become ill or remain healthy. Although drugs have been developed to combat diseases caused by viral infections, their efficacy, unlike those against bacteria and fungi, is limited to certain types of viruses: targets for effective drugs are nucleoside kinases of herpes virus, protease and reverse transcriptase of human immunodeficiency virus, neuraminidase of influenza virus, and non-structural proteins of hepatitis C virus (11–13). Some infectious diseases, such as those caused by Ebola virus and highly pathogenic influenza virus, have been challenging to treat and often result in a large number of deaths (14–17). Therefore, medical treatments that are effective against different types of viruses are urgently required.
We herein highlight an underrepresented virus–host interaction, the apoptosis-dependent phagocytosis of virus-infected cells, which enables the elimination of viruses as an innate immune response. This mechanism may be effective against most types of viruses and appears to be conserved among multicellular organisms. Therefore, it may provide a better rationale for the development of novel medical treatments against virus-induced diseases (18, 19).
Phagocytic Elimination of Cells Undergoing Apoptotic Death
As one of the host responses evoked upon viral infection, host cells are induced to undergo apoptotic death (20, 21). Apoptosis is an orchestrated process of self-demolition, which is observed across metazoan species and considered to be a major form of programmed cell death (22–24). The pathways for the induction of apoptosis have been documented for three model animals—the nematode Caenorhabditis elegans, the fruit fly Drosophila melanogaster, and the mouse Mus musculus—and are shown to be fundamentally equivalent (22, 25, 26), as illustrated in Figure 1. All cellular changes observed during the apoptotic process are generally attributed to the actions of cysteine-proteases, caspases, and the onset of apoptosis involves the activation of initiator caspases that, in turn, partially cleave and activate another group of caspases, the effector caspase (24, 27, 28). Activated effector caspases then cleave a number of cellular proteins, resulting in the structural and biochemical features of apoptosis, such as the shrinkage of cells, fragmentation of DNA, and condensation of chromatin (22).
Figure 1. Similarity in apoptosis-inducing pathways in three model animals. Pathways for the induction of apoptosis in mammals, Drosophila melanogaster, and Caenorhabditis elegans are shown. Not all signal mediators are indicated. In the activation of initiator caspases, the mitochondrion is involved in mammals, probably involved in Drosophila, and not involved in C. elegans. Initiator caspases are caspase-9 in mammals, caspase-9-like Dronc in Drosophila, and absent in C. elegans, while effector caspases are caspase-3 and caspase-7 in mammals, caspase-3-like DrICE and Dcp-1 in Drosophila, and caspase-9-like CED-3 in C. elegans. Effector caspases, once activated by initiator caspases, degrade a number of cellular proteins, leading to structural and functional features that are typical of apoptosis. In mammals, two different modes of apoptosis-inducing pathways exist, and the so-called intrinsic pathway that involves the action of mitochondria is shown. The other one, the extrinsic pathway, which is initiated by extracellular death factors and their receptors independent of mitochondrial actions, is not shown (see Figure 4). CED, cell death abnormal; Dcp-1, death caspase-1; DrICE, Drosophila interleukin-1 β-converting enzyme; Dronc, Drosophila Nedd2-like caspase; Egl-1, egg-laying defective-1.
Apoptotic cells completely disappear: they are engulfed and digested by immune cells, a process-dubbed phagocytosis (29–31). Phagocytosis was described more than 100 years ago through the seminal studies of the late professor Elie Metchnikoff (32, 33). Researchers initially investigated the mechanisms underlying the phagocytosis of microbial pathogens that invade the human body and later identified apoptotic cells as another target. The phagocytosis of microbial pathogens is evident in innate and adaptive immune responses: phagocytes bind to surface structures specific to the target in the former response, while immunoglobulin, which binds antigens on the surface of pathogens and is often called an opsonin, functions as a ligand for an engulfment receptor, i.e., the Fc receptor, of phagocytes in the adaptive response. In contrast, antibodies are not involved in the phagocytosis of apoptotic cells, and the surface structures of the target that undergo modifications during the apoptotic process are recognized by the engulfment receptors of phagocytes. Under certain conditions, soluble proteins called bridging molecules connect apoptotic cells and phagocytes, similar to opsonins; however, these bridging molecules do not include immunoglobulin. Therefore, apoptotic cell clearance is categorized into an innate immune response to eliminate cells unwanted by the body. The phagocytic elimination of cells undergoing apoptosis is so rapidly accomplished that apoptotic cells are rarely detected in tissues and organs. Cells undergoing apoptosis maintain the integrity of plasma membrane permeability until engulfment by phagocytes, and thus the noxious components of cells do not leak out and damage surrounding tissues. Therefore, apoptosis is considered to be a physiological, silent mode of cell death (34, 35).
The entire process of the phagocytosis of apoptotic cells is shown in Figure 2. Apoptotic cells that are close to engulfment release substances, which are often referred to as find-me signals, to recruit phagocytes. A number of molecules have been reported to act as such signals, including proteins, lipids, and nucleotides, and their receptors as well as downstream signal transduction pathways have been mostly identified (36–38). Phagocytosis is initiated when apoptotic cells are in close proximity to phagocytes, which allows engulfment receptors on the surface of phagocytes to recognize and bind to ligands on the surface of target apoptotic cells (34, 35). The ligands for engulfment receptors are called eat-me signals or markers for phagocytosis, which appear on the cell surface during the apoptotic process (37, 39, 40). The engagement of eat-me signals to the corresponding receptors activates signaling pathways that ultimately generate pseudopodia, extensions of plasma membranes that surround and engulf target cells (30, 37, 40). Apoptotic cells are then incorporated, forming specialized membrane vesicles called phagosomes. Phagosomes subsequently fuse with lysosomes, giving rise to phagolysosomes (31, 34), and the components of apoptotic cells are then subjected to digestion through the actions of lysosomal enzymes. There are two partly overlapping pathways for the induction of phagocytosis, which are conserved among the nematode, fruit fly, and mammals (22, 25, 31, 34), as are those for the induction of apoptosis, and are shown in Figure 3. In the figure, the names of eat-me signals, engulfment receptors, and intracellular signal mediators of C. elegans, Drosophila, and mammals are shown. Phosphatidylserine (PS) is an eat-me signal common among these animal species, and transthyretin-like protein 52 (TTR52) in C. elegans and milk fat globule epidermal growth factor protein 8 (MFG-E8) in mammals are PS-binding proteins that bridge apoptotic cells and phagocytes. The C. elegans cell death abnormal protein 1 (CED-1) and its counterparts, Draper in Drosophila and multiple epidermal growth factor-like domains 10 (MEGF10) in mammals, and integrin INA1-PAT3 of C. elegans and its counterparts, αPS3–βν of Drosophila and αv–β3 and αv–β5 of mammals, are engulfment receptors located at the furthest upstream of the two pathways. CED-6 in C. elegans and its counterparts, dCed-6 in Drosophila and engulfment adapter protein (GULP) in mammals, and CED-2 in C. elegans and its counterparts, CT10 regulator of kinase (Crk) in Drosophila, and CrkII in mammals, are adaptor proteins that directly bind the engulfment receptors upon activation by eat-me signals. The C. elegans CED-5 and its counterparts, myoblast city (Mbc) of Drosophila and dedicator of cytokinesis 180 (Dock180) of mammals, are guanine nucleotide exchange factors that activate small G proteins. CED-12 in C. elegans and engulfment and cell motility (ELMO) in mammals are another adaptor proteins constituting one pathway, but their counterpart in Drosophila, dElmo, seems to be dispensable (41). The two pathways converge on the small G proteins CED-10 in C. elegans, Rac1 and Rac2 in Drosophila, and Rac1 in mammals, which remodel the actin cytoskeleton for the generation of pseudopodia. CED-7 in C. elegans and its counterparts, CG1718 in Drosophila and ATP-binding cassette (ABC) protein A1 in mammals, are ABC transporters whose actions in the pathways remain to be solved. Some signal mediators remain missing in these pathways and need to be identified. Other eat-me signals, bridging molecules, engulfment receptors, and signal mediators have been reported, which could be incorporated into the pathways shown here or constitute additional pathways.
Figure 2. Processes of apoptosis-dependent phagocytosis. Cells undergoing apoptosis secrete substances that attract phagocytes (STEP 1), often called find-me signals, and simultaneously express eat-me signals on their surface (STEP 2). Phagocytes that come into close proximity to apoptotic cells recognize and bind eat-me signals using engulfment receptors (STEP 2), and activate signaling pathways for the induction of phagocytosis. The culmination of this signal transduction is the generation of pseudopodia that help phagocytes surround and incorporate apoptotic cells (STEP 3). Materials engulfed exist as phagosomes, which subsequently fuse with the lysosomes for degradation (STEP 4).
Figure 3. Similarity in signaling pathways for the induction of apoptotic cell clearance in three model animals. Molecules constituting two partly overlapping pathways for the induction of phagocytosis in the nematodes, insects, and mammals are shown. The names of eat-me signals, bridging molecules, engulfment receptors, and intracellular signal mediators of Caenorhabditis elegans, Drosophila melanogaster, and mammals are shown from left to right with slashes in between. All molecules in each individual category are counterparts to each other in three animal species. Refer to the text for explanation.
Induction of Apoptosis and Subsequent Phagocytosis of Influenza Virus-Infected Cells
Ranges of cell types, either primarily cultured cells or established cell lines, are susceptible to infection with influenza virus and are subsequently induced to undergo apoptosis (42–47). Previous studies demonstrated that HeLa cells and Madin–Darby canine kidney cells become apoptotic upon influenza A virus infection, characterized by the cleavage of host chromosomal DNA (48), condensation of chromatin (48), surface exposure of PS (49), and activation of initiator and effector caspases (50). Further studies demonstrated that the initiation of apoptosis in HeLa cells infected with influenza H3N2 virus may due to an elevated levels of Fas and the Fas ligand, a death receptor and its ligand (48, 49, 51). Upon infection, the activity of the transcription factor CCAAT/enhancer-binding protein β (C/EBPβ) increased, possibly through the action of double-stranded RNA-activated protein kinase (52), and this factor enhances the transcription of Fas- and Fas ligand-encoding genes (51, 53). Influenza virus-infected cells with elevated levels of Fas and the Fas ligand on the cell surface most likely interact with each other for the induction of apoptosis (54) (Figure 4). Besides the above-described study, influenza virus-induced cell death also appears to occur through the actions of apoptosis-inducing factor, another cell death-inducing ligand, in the human alveolar epithelial cell line A549, independent of caspases (55), and the upregulated expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and tumor necrosis factor-α was observed in human monocyte-derived macrophages exposed to influenza H5N1 virus (56). Similarly, the induction of TRAIL was reported in natural killer cells, helper T cells, and cytotoxic T cells during infection with influenza H1N1 virus (57). Viral clearance was found to be markedly delayed in the presence of an anti-TRAIL monoclonal antibody, suggesting an important role for TRAIL in the antiviral immune response (57). A recent study demonstrated that the upregulated expression of B-cell lymphoma-2-associated X protein may be an alternative cause of the induction of apoptosis in influenza virus-infected cells (58). Nevertheless, all findings revealed that influenza virus-infected cells were induced to undergo apoptotic cell death (48, 59–61).
Figure 4. Fas and Fas ligand-induced apoptosis in influenza virus-infected cells. Upon infection with influenza virus, the production of the death receptor Fas and its ligand, the Fas ligand, is enhanced at the level of gene transcription. As a result, virus-infected cells have higher levels of Fas and the Fas ligand on their surface. When these cells associate with each other, the ligand-engaged receptor activates an intracellular signaling pathway for the induction of apoptosis. This mode of apoptosis induction is called the extrinsic pathway and does not involve mitochondria (see Figure 1).
Although typical apoptosis mediated by caspases is evident in influenza virus-infected cells, virus replication in these cells did not appear to be impaired (48). This may be because this type of virus rapidly produces its progeny after entering host cells. In order to examine the role of apoptosis, we investigated whether influenza virus-infected cells are targeted for engulfment by phagocytes. The findings obtained from an assay for phagocytosis in vitro using mouse peritoneal macrophages as phagocytes showed that HeLa cells became susceptible to phagocytosis when infected with influenza A virus (62), and that this leads to the inhibition of viral propagation (63). The phagocytosis of influenza virus-infected cells appeared to be mediated by PS, the eat-me signal characterized in the most detail, and carbohydrate moieties on the surface of macrophages, which are modified by influenza virus neuraminidase expressed in virus-infected cells (62, 64) (Figure 5). Further investigations using an in-vivo model of infection in mice revealed the involvement of macrophages and neutrophils in the phagocytosis of cells infected with influenza A virus, and this contributed to the mitigation of influenza pathologies in mice (65). Find-me signals responsible for the recruitment of these phagocytes to the site of virus-infected cells remain to be known. The phagocytic activity of alveolar macrophages prepared from influenza virus-infected mice was stronger than that of macrophages from uninfected counterparts (65). Furthermore, the increased mortality of Toll-like receptor 4-lacking mice infected with influenza virus suggested a role for this pattern recognition receptor in antiviral mechanisms (65). The rapid mobilization of neutrophils and macrophages to target sites soon after influenza virus infection may explain the importance of pattern recognition receptors (65). Collectively, apoptosis in influenza virus-infected cells makes them susceptible to phagocytosis, and this mechanism for the direct elimination of the virus serves as an antiviral immune response.
Figure 5. PS-mediated and sugar residue-stimulated phagocytosis of influenza virus-infected cells. Influenza virus-infected cells are induced to undergo apoptosis and express PS and viral NA on their surfaces. When phagocytes, macrophages and neutrophils, bind to these cells through interactions between PS and a PS-recognizing engulfment receptor, NA enzymatically modifies sugar residues that exist on the surface of phagocytes. The PS-bound receptor activates a signaling pathway for the induction of phagocytosis, while modified sugar residues somehow stimulate phagocytosis. NA, neuraminidase; PS, phosphatidylserine.
Induction of Apoptosis and Subsequent Phagocytosis of Drosophila C Virus-Infected Cells
We then examined whether a similar antiviral mechanism exists in insects with no adaptive immunity. We used D. melanogaster as a host for infection with Drosophila C virus (DCV), a natural pathogen of Drosophila (66, 67). DCV is a non-enveloped, positive-strand picorna-like RNA virus that belongs to the Dicitroviridae genus Cripavirus (66, 68). When S2 cells, a Drosophila culture cell line, were incubated with DCV, they underwent apoptosis, as was evident from chromatin condensation, DNA fragmentation, and caspase activation, accompanied by the propagation of the virus (69). We found that the amount of Drosophila inhibitor of apoptosis protein 1 (DIAP1), a Drosophila protein that inhibits caspases, decreased upon infection with DCV. All these changes in S2 cells after viral infection became undetectable when a synthetic inhibitor of caspase was present in cell cultures or the virus was pretreated with UV. The mechanisms underlying apoptosis in DCV-infected cells have not yet been elucidated; however, several studies suggested the involvement of a mechanism similar to that observed during the early developmental stages of Drosophila (69–71). Upon infection with Flock house virus or the DNA virus Autographa californica multicapsid nucleopolyhedrovirus, the expression of reaper and head involution defective (hid), the products of which antagonize DIAP1, was significantly increased in a manner mediated by the transcription control regions of the two genes, namely, a p53-bound sequence and sequence named the irradiation-responsive enhancer region (71). A similar mechanism appears to exist in mosquitoes when they are infected with Culex nigripalpus nucleopolyhedrovirus (72). We anticipate the following pathway for the induction of apoptosis in DCV-infected cells, as shown in Figure 6: the propagation of the virus enhances the transcription of reaper and hid; Reaper and/or Hid suppress DIAP1; the initiator caspase Drosophila Nedd2-like caspase (Dronc) is activated; Dronc cleaves and activates the effector caspases Drosophila interleukin-1 β-converting enzyme (DrICE) and death caspase-1 (Dcp-1); and the activated effector caspases degrade cellular proteins.
Figure 6. Possible mechanism for the induction of apoptosis in Drosophila C virus-infected cells. The process for the propagation of the virus somehow increases pro-apoptotic proteins Reaper and Hid, which cause a decrease in the level of DIAP1. This leads to the liberation and, thus, activation of the initiator caspase Dronc that partially cleaves the effector caspases DrICE and Dcp-1 for activation. Activated DrICE and Dcp-1, in turn, cleave a number of cellular proteins for apoptotic changes. The brownish dot at the end of the viral genome indicates a viral protein called virion protein, genome-linked, which plays a role in the synthesis of viral RNA. Dcp-1, death caspase-1; DIAP1, Drosophila inhibitor of apoptosis protein 1; DrICE, Drosophila interleukin-1 β-converting enzyme; Dronc, Drosophila Nedd2-like caspase.
The presence of l(2)mbn cells, a Drosophila cell line derived from larval hemocytes, in cultures of DCV-infected S2 cells induced a decrease in the amount of the virus (69). Therefore, we examined whether DCV-infected cells are phagocytosed in a manner that is dependent on apoptosis and found that this was the case. Phagocytosis was partly inhibited in the presence of a PS-containing liposome that interferes with the action of this phospholipid as an eat-me signal. Drosophila phagocytes used the engulfment receptors Draper and integrin αPS3–βν for the phagocytosis of apoptotic cells (30), and the inhibited expression of either receptor by RNA interference (RNAi) caused a decrease in the level of phagocytosis. Phagocytosis was decreased further after the simultaneous RNAi of both receptors. These findings collectively suggested that DCV-infected cells are subjected to apoptosis-dependent phagocytosis by Drosophila phagocytes, depending on, at least partly, the eat-me signal PS and engulfment receptors Draper and integrin αPS3–βν. In order to assess this in vivo, we established a fatal infection of Drosophila adults with DCV. The findings of an assay for survivorship revealed that Draper and integrin αPS3–βν were both involved in the protection of flies from viral infection. Measurements of the viral load during infection indicated that these engulfment receptors were responsible for reducing viral propagation in adult flies. The ectopic expression of a PS-binding protein made flies more severely succumb to DCV infection and increased the viral load, confirming the PS-mediated phagocytosis of DCV-infected cells in adult flies. Hemocytes contained in the adult hemocoel appeared to be responsible for the phagocytosis of virus-infected cells. These findings indicate that the PS-mediated, Draper and integrin αPS3–βν-dependent phagocytosis of DCV-infected, apoptotic cells by hemocytes plays a role in antiviral mechanisms in Drosophila (see Figure 3).
In Drosophila, RNAi-based antiviral innate immunity has been intensely investigated (73–81). Our study now adds another mechanism for the immune response, i.e., the apoptosis-dependent, phagocytosis-based elimination of virus-infected cells. A recent study demonstrated that Drosophila hemocytes spread double-stranded RNA, which induces virus-specific RNAi, in the entire body of adult flies upon viral infection; therefore, cells uninfected with the virus acquired the competence for RNAi (82). The phagocytosis of virus-infected cells may make hemocytes gain a source for the production of double-stranded RNA. More importantly, the apoptosis-dependent phagocytosis of virus-infected cells serves as an antiviral mechanism in Drosophila, which is only equipped with innate immunity, indicating that this mechanism is an innate immune response against viral infection and common among multicellular organisms.
Contribution of Apoptosis-Dependent Phagocytosis to Immunity Control
Recent studies on the mechanisms and consequences of apoptosis-dependent phagocytosis have revealed that this type of phagocytosis achieves not only the elimination of unwanted cells but also endows additional effects that contribute to the maintenance of tissue homeostasis. These effects may cooperatively control, with the direct removal of virus-infected cells, immunity to fight against viral infection, as shown in Figure 7.
Figure 7. Orchestrated antiviral mechanisms initiated by the phagocytosis of virus-infected cells. Virus-infected cells are subjected to apoptosis-dependent phagocytosis, which results in the digestion of viruses together with host cells, Virus Removal. At the same time, phagocytes process incorporated viral proteins for the presentation of antigens toward CTLs for their activation, Antigen Presentation. Moreover, phagocytes change the pattern of gene expression at a transcriptional level, so that the repertoire of cytokines shifts to the mitigation of inflammation, Inflammation Resolution; the phagocytic activity of phagocytes is enhanced, Trained Immunity; and virus-specific RNAi is systemically induced, Trained Immunity. CTLs, cytotoxic T lymphocytes.
Antigen Presentation
The presentation of antigens by certain types of immune cells toward T lymphocytes is a prerequisite for the induction of adaptive immunity. Antigen presentation is mainly accomplished by dendritic cells and macrophages, antigen-presenting cells (APCs), which sample the peptides of foreign materials, such as microbial pathogens, and expose them on the cell surface together with the major histocompatibility complex (83–86). Although APCs may process the foreign peptides synthesized in these cells, the presentation of microbial antigens by APCs that are apparently not infected with the corresponding pathogens is often observed, and this is an immunological process called cross-presentation (84, 87–89). Apoptosis-dependent phagocytosis provides a mechanistic basis for this phenomenon; APCs that are not infected by the virus engulf virus-infected cells undergoing apoptosis, process viral proteins, and present viral antigens to cytotoxic T lymphocytes (CTLs) for their activation (90, 91). Activated CTLs induce apoptosis in cells that are infected with the same virus. Therefore, the phagocytosis of virus-infected cells may lead to the activation of adaptive immune responses.
Inflammation Resolution
The phagocytic elimination of cells undergoing apoptotic cell death is an immunologically silent reaction; inflammation is not evoked. Previous research by Fadok, Henson, and others demonstrated that this mode of phagocytosis more actively resolves inflammation (92–95). They showed that macrophages engulf apoptotic neutrophils to remove cells that produce and secrete pro-inflammatory cytokines, and that neutrophil-engulfing macrophages simultaneously secrete anti-inflammatory cytokines such as transforming growth factor-β. Therefore, phagocytes alter the repertoire of cytokines after the engulfment of virus-infected cells so that possible inflammation ceases in addition to the direct elimination of virus.
Trained Immunity
In animals equipped with innate and adaptive immunity, the first encounter with foreign substances such as microbial pathogens makes the host organism prepare for a second encounter with the same substances (96, 97). In the first encounter, the major players to combat invaders are the components of innate immunity, and they take actions not only to eliminate the invaders but also setup the activation of adaptive immunity so that adaptive responses are evoked in a rapid and robust manner in the second encounter, a mechanism called trained immunity or immunological memory. The culmination of trained immunity that involves apoptotic cell clearance is expected to be antigen presentation as described above.
Until recently, trained immunity was generally considered to not exist in innate immunity, which does not involve antibodies and lymphocytes. However, recent studies using Drosophila cast doubts on this assumption. Hemocytes, Drosophila macrophages, exhibit enhanced phagocytic activity when they encounter targets, namely, bacteria (98) and apoptotic cells (41). This is regarded as preparation for the next encounter with the same targets in order to eliminate them. The enhancement of phagocytic activity observed in both studies may have been due to a higher level of engulfment receptors. An increase of engulfment receptors in phagocytes after phagocytosis was previously reported for mammalian macrophages (96, 97), and, thus, trained immunity that leads to the activation of phagocytes is most likely conserved among multicellular organisms. Our findings also demonstrated that gene expression patterns in phagocytes changed after the engulfment of apoptotic cells, including the enhanced transcription of genes coding for engulfment receptors (41). In addition, a change in the mode of cytokine production in macrophages appears to occur at the level of transcription (99). Therefore, the mode of gene transcription appears to change in phagocytes upon the engulfment of apoptotic cells in order to more effectively control tissue homeostasis.
Concluding Remarks
Most living organisms are always exposed to potentially fatal infections by viruses and, thus, have acquired several distinct mechanisms to prevent the invasion, proliferation, and release of viruses. The apoptosis-dependent phagocytosis of virus-infected cells is one such mechanism, through which organisms directly remove viruses from the body. Cells are induced to undergo apoptosis upon infection with a number of viruses, and this process inactivates the cellular machineries for gene expression and proliferation, which are required by invading viruses to produce their progeny in infected cells. Although apoptosis itself retards the growth of invaders, virus-infected cells appear to be equipped with a more active process, subsequent to apoptosis, for the direct elimination of viruses; virus-infected cells become susceptible to phagocytosis for degradation. Recent studies demonstrated that not only apoptotic cells, but also those undergoing other types of cell death are subjected to phagocytic elimination (100–102). Nevertheless, apoptosis remains a major biological process for the safe removal of cells unwanted by the body because it is the only mode of cell death during which the control of plasma membrane permeability is maintained. As opposed to viruses, Leishmania major, an intracellular parasite, appears to exploit the mechanisms described above for the establishment and dissemination of infection (103). Upon entry into animals, these types of protozoa are first captured by neutrophils that subsequently undergo apoptosis. Then, L. major-infected, apoptotic neutrophils are phagocytosed by macrophages, which are primary host cells for these protozoa. The pathogens survive and replicate in macrophages, and, at the same time, macrophages create an anti-inflammatory environment. As a result, L. major disseminates its infection. The mechanisms by which L. major evades killing and digestion in neutrophils and macrophages remain to be clarified.
Individual processes that constitute the apoptosis-dependent phagocytosis of virus-infected cells may be targeted by the development of novel medical treatments against virus-induced diseases. The enhancement of apoptosis in virus-infected cells may be one such treatment. Apoptosis is induced in cells that ideally need to be retained, and, thus, this treatment needs to be restricted to cells infected with viruses. In order to achieve this, the mechanisms underlying virus-induced apoptosis need to be elucidated in more detail. Another concern is the presence of proteins that inhibit apoptosis by antagonizing caspases in some types of viruses, particularly DNA viruses (20, 21, 104). The development of a method to repress apoptosis-inhibiting viral proteins may be an effective treatment. On the other hand, molecules involved in the process of the phagocytosis of virus-infected cells have been largely identified, and the stimulation of phagocytic activity is not always harmful to health. A substance that acts as an agonist for engulfment receptors is a promising candidate for an effective drug. Alternatively, the secondary effects of the phagocytosis of apoptotic cells may be targeted. The administration of apoptotic cells to patients may contribute to mitigating inflammation and stimulating phagocytes, and antiviral adaptive immunity is expected when apoptotic cells harboring viral antigens are used to treat patients. However, such efforts toward inventing novel medical treatments require great care, because the apoptosis-dependent phagocytosis of microbe-infected cells could favor the pathogens, as an example shown above.
Author Contributions
FN mostly conducted the experiments in our study quoted in this review. FN, AS, and YN wrote the paper.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
A word of thanks goes to Rudi Arfiansyah, S.Si., Apt of Hasanuddin University, for his kind support in preparing the figures. We also thank the members of the Laboratory of Host Defense and Responses for discussion.
Funding
This work was partly supported by KAKENHI Grant from Japan Society for the Promotion of Science (to AS and YN) and a Directorate General of Higher Education scholarship from the Ministry of Research, Technology, and Higher Education of the Republic of Indonesia (to FN).
References
1. Pedulla ML, Ford ME, Houtz JM, Karthikeyan T, Wadsworth C, Lewis JA, et al. Origins of highly mosaic mycobacteriophage genomes. Cell (2003) 113:171–82. doi:10.1016/S0092-8674(03)00233-2
2. Edwards RA, Rohwer F. Viral metagenomics. Nat Rev Microbiol (2005) 3:504–10. doi:10.1038/nrmicro1163
3. Kucharski AJ, Kwok KO, Wei VWI, Cowling BJ, Read JM, Lessler J, et al. The contribution of social behaviour to the transmission of influenza A in a human population. PLoS Pathog (2014) 10:e1004206. doi:10.1371/journal.ppat.1004206
4. Lindahl JF, Grace D. The consequences of human actions on risks for infectious diseases: a review. Infect Ecol Epidemiol (2015) 5:30048. doi:10.3402/iee.v5.30048
5. Breitbart M, Rohwer F. Here a virus, there a virus, everywhere the same virus? Trends Microbiol (2005) 13:278–84. doi:10.1016/j.tim.2005.04.003
6. Schmid M, Speiseder T, Dobner T, Gonzalez RA. DNA virus replication compartments. J Virol (2014) 88:1404–20. doi:10.1128/JVI.02046-13
7. Novoa RR, Calderita G, Arranz R, Fontana J, Granzow H, Risco C. Virus factories: associations of cell organelles for viral replication and morphogenesis. Biol Cell (2005) 97:147–72. doi:10.1042/BC20040058
8. Netherton CL, Wileman T. Virus factories, double membrane vesicles and viroplasm generated in animal cells. Curr Opin Virol (2011) 1:381–7. doi:10.1016/j.coviro.2011.09.008
11. De Clercq E, Li G. Approved antiviral drugs over the past 50 years. Clin Microbiol Rev (2016) 29:695–747. doi:10.1128/cmr.00102-15
12. Wegzyn CM, Wyles DL. Antiviral drug advances in the treatment of human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV). Curr Opin Pharmacol (2012) 12:556–61. doi:10.1016/j.coph.2012.06.005
13. De Clercq E. Antiviral drugs in current clinical use. J Clin Virol (2004) 30:115–33. doi:10.1016/j.jcv.2004.02.009
14. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet (2011) 377:849–62. doi:10.1016/S0140-6736(10)60667-8
15. Ströher U, Feldmann H. Progress towards the treatment of Ebola haemorrhagic fever. Exp Opin Investig Drugs (2006) 15:1523–35. doi:10.1517/13543784.15.12.1523
16. De Clercq E. Strategies in the design of antiviral drugs. Nat Rev Drug Discov (2002) 1:13–25. doi:10.1038/nrd703
17. Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature (2006) 442:448–52. doi:10.1038/nature04795
18. Martins N, Imler J-L, Meignin C. Discovery of novel targets for antivirals: learning from flies. Curr Opin Virol (2016) 20:64–70. doi:10.1016/j.coviro.2016.09.005
19. Majzoub K, Hafirassou Mohamed L, Meignin C, Goto A, Marzi S, Fedorova A, et al. RACK1 controls IRES-mediated translation of viruses. Cell (2014) 159:1086–95. doi:10.1016/j.cell.2014.10.041
20. Roulston A, Marcellus RC, Branton PE. Viruses and apoptosis. Annu Rev Microbiol (1999) 53:577–628. doi:10.1146/annurev.micro.53.1.577
21. Barber GN. Host defense, viruses and apoptosis. Cell Death Differ (2001) 8:113–26. doi:10.1038/sj.cdd.4400823
22. Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell (2011) 147:742–58. doi:10.1016/j.cell.2011.10.033
23. Fogarty CE, Bergmann A. The sound of silence: signaling by apoptotic cells. Curr Top Dev Biol (2015) 114:241–65. doi:10.1016/bs.ctdb.2015.07.013
24. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol (2008) 9:231–41. doi:10.1038/nrm2312
25. Hay BA, Huh JR, Guo M. The genetics of cell death: approaches, insights and opportunities in Drosophila. Nat Rev Genet (2004) 5:911–22. doi:10.1038/nrg1491
26. Stuart LM, Ezekowitz RA. Phagocytosis and comparative innate immunity: learning on the fly. Nat Rev Immunol (2008) 8:131–41. doi:10.1038/nri2240
27. Nagata S, Tanaka M. Programmed cell death and the immune system. Nat Rev Immunol (2017) 17:333–40. doi:10.1038/nri.2016.153
28. Bergmann A, Steller H. Apoptosis, stem cells, and tissue regeneration. Sci Signal (2010) 3:re8. doi:10.1126/scisignal.3145re8
29. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ (2007) 15:243–50. doi:10.1038/sj.cdd.4402184
30. Nakanishi Y, Nagaosa K, Shiratsuchi A. Phagocytic removal of cells that have become unwanted: implications for animal development and tissue homeostasis. Dev Growth Differ (2011) 53:149–60. doi:10.1111/j.1440-169X.2010.01224.x
31. Hochreiter-Hufford A, Ravichandran KS. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol (2013) 5:a008748. doi:10.1101/cshperspect.a008748
32. Gordon S. Phagocytosis: an immunobiologic process. Immunity (2016) 44:463–75. doi:10.1016/j.immuni.2016.02.026
33. Tauber AI. Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol (2003) 4:897–901. doi:10.1038/nrm1244
34. Arandjelovic S, Ravichandran KS. Phagocytosis of apoptotic cells in homeostasis. Nat Immunol (2015) 16:907–17. doi:10.1038/ni.3253
35. Lauber K, Blumenthal SG, Waibel M, Wesselborg S. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell (2004) 14:277–87. doi:10.1016/S1097-2765(04)00237-0
36. Peter C, Wesselborg S, Herrmann M, Lauber K. Dangerous attraction: phagocyte recruitment and danger signals of apoptotic and necrotice cells. Apoptosis (2010) 15:1007–28. doi:10.1007/s10495-010-0472-1
37. Ravichandran KS. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity (2011) 35:445–55. doi:10.1016/j.immuni.2011.09.004
38. Medina CB, Ravichandran KS. Do not let death do us part: ‘find-me’ signals in communication between dying cells and the phagocytes. Cell Death Differ (2016) 23:979–89. doi:10.1038/cdd.2016.13
39. Ravichandran KS. “Recruitment signals” from apoptotic cells: invitation to a quiet meal. Cell (2003) 113:817–20. doi:10.1016/s0092-8674(03)00471-9
40. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol (2007) 7:964–74. doi:10.1038/nri2214
41. Nonaka S, Ando Y, Kanetani T, Hoshi C, Nakai Y, Nainu F, et al. Signaling pathway for phagocyte priming upon encounter with apoptotic cells. J Biol Chem (2017) 292:8059–72. doi:10.1074/jbc.M116.769745
42. Nichols JE, Niles JA, Roberts NJ. Human lymphocyte apoptosis after exposure to influenza A virus. J Virol (2001) 75:5921–9. doi:10.1128/jvi.73.13.5921-5929.2001
43. Brydon EWA, Smith H, Sweet C. Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release. J Gen Virol (2003) 84:2389–400. doi:10.1099/vir.0.18913-0
44. Mok CKP, Lee DCW, Cheung C-Y, Peiris M, Lau ASY. Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. J Gen Virol (2007) 88:1275–80. doi:10.1099/vir.0.82423-0
45. Thitithanyanont A, Engering A, Ekchariyawat P, Wiboon-ut S, Limsalakpetch A, Yongvanitchit K, et al. High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-α and TLR ligands. J Immunol (2007) 179:5220–7. doi:10.4049/jimmunol.179.8.5220
46. Daidoji T, Koma T, Du A, Yang C-S, Ueda M, Ikuta K, et al. H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells. J Virol (2008) 82:11294–307. doi:10.1128/jvi.01192-08
47. Gu J, Xie Z, Gao Z, Liu J, Korteweg C, Ye J, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet (2007) 370:1137–45. doi:10.1016/S0140-6736(07)61515-3
48. Takizawa T, Matsukawa S, Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol (1993) 74:2347–55. doi:10.1099/0022-1317-74-11-2347
49. Fujimoto I, Takizawa T, Ohba Y, Nakanishi Y. Co-expression of Fas and Fas-ligand on the surface of influenza virus-infected cells. Cell Death Differ (1998) 5:426–31. doi:10.1038/sj.cdd.4400362
50. Takizawa T, Tatematsu C, Ohashi K, Nakanishi Y. Recruitment of apoptotic cysteine proteases (caspases) in influenza virus-induced cell death. Microbiol Immunol (1999) 43:245–52. doi:10.1111/j.1348-0421.1999.tb02400.x
51. Wada N, Matsumura M, Ohba Y, Kobayashi N, Takizawa T, Nakanishi Y. Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J Biol Chem (1995) 270:18007–12. doi:10.1074/jbc.270.30.18007
52. Takizawa T, Ohashi K, Nakanishi Y. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J Virol (1996) 70:8128–32.
53. Takizawa T, Fukuda R, Miyawaki T, Ohashi K, Nakanishi Y. Activation of the apoptotic Fas antigen-encoding gene upon influenza virus infection involving spontaneously produced beta-interferon. Virology (1995) 209:288–96. doi:10.1006/viro.1995.1260
54. Nakanishi Y, Hashimoto Y, Takizawa T, Shiratsuchi A. Mechanisms and consequences of phagocytosis of influenza virus-infected cells. Antiinflamm Antiallergy Agents Med Chem (2008) 7:97–100. doi:10.2174/187152308784533122
55. Qu X, Ding X, Duan M, Yang J, Lin R, Zhou Z, et al. Influenza virus infection induces translocation of apoptosis-inducing factor (AIF) in A549 cells: role of AIF in apoptosis and viral propagation. Arch Virol (2017) 162:669–75. doi:10.1007/s00705-016-3151-x
56. Zhou J, Law HKW, Cheung CY, Ng IHY, Peiris JSM, Lau YL. Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages. J Infect Dis (2006) 193:945–53. doi:10.1086/500954
57. Ishikawa E, Nakazawa M, Yoshinari M, Minami M. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice. J Virol (2005) 79:7658–63. doi:10.1128/jvi.79.12.7658-7663.2005
58. Fan N, Wang J. MicroRNA 34a contributes to virus-mediated apoptosis through binding to its target gene Bax in influenza A virus infection. Biomed Pharmacother (2016) 83:1464–70. doi:10.1016/j.biopha.2016.08.049
59. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y. In vivo induction of apoptosis by influenza virus. J Gen Virol (1995) 76:2869–73. doi:10.1099/0022-1317-76-11-2869
60. Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol (1994) 68:3667–73.
61. Fesq H, Bacher M, Nain M, Gemsa D. Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 190:175–82. doi:10.1016/S0171-2985(11)80292-5
62. Shiratsuchi A, Kaido M, Takizawa T, Nakanishi Y. Phosphatidylserine-mediated phagocytosis of influenza A virus-infected cells by mouse peritoneal macrophages. J Virol (2000) 74:9240–4. doi:10.1128/JVI.74.19.9240-9244.2000
63. Fujimoto I, Pan J, Takizawa T, Nakanishi Y. Virus clearance through apoptosis-dependent phagocytosis of influenza A virus-infected cells by macrophages. J Virol (2000) 74:3399–403. doi:10.1128/JVI.74.7.3399-3403.2000
64. Watanabe Y, Shiratsuchi A, Shimizu K, Takizawa T, Nakanishi Y. Role of phosphatidylserine exposure and sugar chain desialylation at the surface of influenza virus-infected cells in efficient phagocytosis by macrophages. J Biol Chem (2002) 277:18222–8. doi:10.1074/jbc.M201074200
65. Hashimoto Y, Moki T, Takizawa T, Shiratsuchi A, Nakanishi Y. Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol (2007) 178:2448–57. doi:10.4049/jimmunol.178.4.2448
66. Xu J, Cherry S. Viruses and antiviral immunity in Drosophila. Dev Comp Immunol (2014) 42:67–84. doi:10.1016/j.dci.2013.05.002
67. Kapun M, Nolte V, Flatt T, Schlötterer C. Host range and specificity of the Drosophila C virus. PLoS One (2010) 5:e12421. doi:10.1371/journal.pone.0012421
68. Marques JT, Imler J-L. The diversity of insect antiviral immunity: insights from viruses. Curr Opin Microbiol (2016) 32:71–6. doi:10.1016/j.mib.2016.05.002
69. Nainu F, Tanaka Y, Shiratsuchi A, Nakanishi Y. Protection of insects against viral infection by apoptosis-dependent phagocytosis. J Immunol (2015) 195:5696–706. doi:10.4049/jimmunol.1500613
70. Settles EW, Friesen PD. Flock house virus induces apoptosis by depletion of Drosophila inhibitor-of-apoptosis protein DIAP1. J Virol (2008) 82:1378–88. doi:10.1128/JVI.01941-07
71. Liu B, Behura SK, Clem RJ, Schneemann A, Becnel J, Severson DW, et al. P53-mediated rapid induction of apoptosis conveys resistance to viral infection in Drosophila melanogaster. PLoS Pathog (2013) 9:e1003137. doi:10.1371/journal.ppat.1003137
72. Liu B, Becnel JJ, Zhang Y, Zhou L. Induction of reaper ortholog mx in mosquito midgut cells following baculovirus infection. Cell Death Differ (2011) 18:1337–45. doi:10.1038/cdd.2011.8
73. Lamiable O, Imler J-L. Induced antiviral innate immunity in Drosophila. Curr Opin Microbiol (2014) 20:62–8. doi:10.1016/j.mib.2014.05.006
74. Sabin LR, Hanna SL, Cherry S. Innate antiviral immunity in Drosophila. Curr Opin Immunol (2010) 22:4–9. doi:10.1016/j.coi.2010.01.007
75. Karlikow M, Goic B, Saleh M-C. RNAi and antiviral defense in Drosophila: setting up a systemic immune response. Dev Comp Immunol (2014) 42:85–92. doi:10.1016/j.dci.2013.05.004
76. Kemp C, Imler J-L. Antiviral immunity in Drosophila. Curr Opin Immunol (2009) 21:3–9. doi:10.1016/j.coi.2009.01.007
77. Buchon N, Silverman N, Cherry S. Immunity in Drosophila melanogaster: from microbial recognition to whole-organism physiology. Nat Rev Immunol (2014) 14:796–810. doi:10.1038/nri3763
78. Wang X-H, Aliyari R, Li W-X, Li H-W, Kim K, Carthew R, et al. RNA interference directs innate immunity against viruses in adult Drosophila. Science (2006) 312:452–4. doi:10.1126/science.1125694
79. Mueller S, Gausson V, Vodovar N, Deddouche S, Troxler L, Perot J, et al. RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila. Proc Natl Acad Sci U S A (2010) 107:19390–5. doi:10.1073/pnas.1014378107
80. Kemp C, Mueller S, Goto A, Barbier V, Paro S, Bonnay F, et al. Broad RNA interference-mediated antiviral immunity and virus-specific inducible responses in Drosophila. J Immunol (2013) 190:650–8. doi:10.4049/jimmunol.1102486
81. Spellberg MJ, Marr MT. FOXO regulates RNA interference in Drosophila and protects from RNA virus infection. Proc Natl Acad Sci U S A (2015) 112:14587–92. doi:10.1073/pnas.1517124112
82. Tassetto M, Kunitomi M, Andino R. Circulating immune cells mediate a systemic RNAi-based adaptive antiviral response in Drosophila. Cell (2017) 169:314–25.e13. doi:10.1016/j.cell.2017.03.033
83. Watts C, Amigorena S. Phagocytosis and antigen presentation. Semin Immunol (2001) 13:373–9. doi:10.1006/smim.2001.0334
84. Savina A, Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunol Rev (2007) 219:143–56. doi:10.1111/j.1600-065X.2007.00552.x
85. Blander JM, Medzhitov R. On regulation of phagosome maturation and antigen presentation. Nat Immunol (2006) 7:1029–35. doi:10.1038/ni1006-1029
86. Lim JJ, Grinstein S, Roth Z. Diversity and versatility of phagocytosis: roles in innate immunity, tissue remodeling, and homeostasis. Front Cell Infect Microbiol (2017) 7:191. doi:10.3389/fcimb.2017.00191
87. Amigorena S, Savina A. Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Immunol (2010) 22:109–17. doi:10.1016/j.coi.2010.01.022
88. Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, Laplante A, et al. Phagosomes are competent organelles for antigen cross-presentation. Nature (2003) 425:402–6. doi:10.1038/nature01912
89. Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 12:557–69. doi:10.1038/nri3254
90. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol (2002) 20:621–67. doi:10.1146/annurev.immunol.20.100301.064828
91. Heath WR, Carbone FR. Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol (2001) 1:126–34. doi:10.1038/35100512
92. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 101:890–8. doi:10.1172/JCI1112
93. Fadok VA, McDonald PP, Bratton DL, Henson PM. Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem Soc Trans (1998) 26:653–6. doi:10.1042/bst0260653
94. Fadok VA, Chimini G. The phagocytosis of apoptotic cells. Semin Immunol (2001) 13:365–72. doi:10.1006/smim.2001.0333
95. Chung EY, Kim SJ, Ma XJ. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res (2006) 16:154–61. doi:10.1038/sj.cr.7310021
96. Sarang Z, Joós G, Garabuczi É, Rühl R, Gregory CD, Szondy Z. Macrophages engulfing apoptotic cells produce nonclassical retinoids to enhance their phagocytic capacity. J Immunol (2014) 192:5730–8. doi:10.4049/jimmunol.1400284
97. A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity (2009) 31:245–58. doi:10.1016/j.immuni.2009.06.018
98. Weavers H, Evans Iwan R, Martin P, Wood W. Corpse engulfment generates a molecular memory that primes the macrophage inflammatory response. Cell (2016) 165:1658–71. doi:10.1016/j.cell.2016.04.049
99. Xiao YQ, Freire-de-Lima CG, Schiemann WP, Bratton DL, Vandivier RW, Henson PM. Transcriptional and translational regulation of TGF-β production in response to apoptotic cells. J Immunol (2008) 181:3575–85. doi:10.4049/jimmunol.181.5.3575
100. Krysko DV, D’Herde K, Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis (2006) 11:1709–26. doi:10.1007/s10495-006-9527-8
101. Petrovski G, Ayna G, Májai G, Hodrea J, Benkő S, Mádi A, et al. Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1β release in human macrophages. Autophagy (2011) 7:321–30. doi:10.4161/auto.7.3.14583
102. Li Z, Venegas V, Nagaoka Y, Morino E, Raghavan P, Audhya A, et al. Necrotic cells actively attract phagocytes through the collaborative action of two distinct PS-exposure mechanisms. PLoS Genet (2015) 11:e1005285. doi:10.1371/journal.pgen.1005285
103. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, Solbach W, et al. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol (2004) 173:6521–5. doi:10.4049/jimmunol.173.11.6521
Keywords: viral infection, apoptosis, phagocytosis, innate immunity, antiviral mechanism
Citation: Nainu F, Shiratsuchi A and Nakanishi Y (2017) Induction of Apoptosis and Subsequent Phagocytosis of Virus-Infected Cells As an Antiviral Mechanism. Front. Immunol. 8:1220. doi: 10.3389/fimmu.2017.01220
Received: 01 August 2017; Accepted: 14 September 2017;
Published: 28 September 2017
Edited by:
Estee Kurant, University of Haifa, IsraelReviewed by:
Junji Xing, Houston Methodist Research Institute, United StatesClaudia Ida Brodskyn, Centro de Pesquisa Gonçalo Moniz-FIOCRUZ/BA, Brazil
Copyright: © 2017 Nainu, Shiratsuchi and Nakanishi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Firzan Nainu, firzannainu@unhas.ac.id;
Yoshinobu Nakanishi, nakanaka@p.kanazawa-u.ac.jp